Benzinga | Aug 11, 2020 04:29PM EDT

Altimmune Q2 EPS $(0.94) Misses $(0.40) Estimate, Sales $700.00K Miss $1.10M Estimate

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.94) per share which missed the analyst consensus estimate of $(0.40) by 135 percent. This is a 261.54 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $700.00 thousand which missed the analyst consensus estimate of $1.10 million by 36.36 percent. This is a 56.95 percent decrease over sales of $1.63 million the same period last year.